Oncolytics Biotech, Inc. (ONCY)

0.8432 -0.01 (-1.55%) USD  |  NASDAQ  |  Sep 04, 16:00
0.8417 0.00 (0.00%) After-Hours: 20:00
More

Oncolytics Biotech Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for ONCY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to 2000. Start Trial.
Date Value
December 31, 2000 --

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Anixa Biosciences, Inc. --
Vicapsys Life Sciences, Inc. --